# Sitagliptin Dose Determination Study

> **NCT01530178** · PHASE4 · COMPLETED · sponsor: **Albert Einstein College of Medicine** · enrollment: 8 (actual)

## Conditions studied

- Diabetes Mellitus, Type 1

## Interventions

- **DRUG:** Sitagliptin
- **DRUG:** Placebo Oral Tablet

## Key facts

- **NCT ID:** NCT01530178
- **Lead sponsor:** Albert Einstein College of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2018-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01530178

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01530178, "Sitagliptin Dose Determination Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01530178. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*